| 16961 |
|
Bartlett J.M.S. |
Ovarian Cancer. Methods and Protocols |
2000 | •• |
| 16960 |
|
Boyle W.J. |
Osteoprotegerin |
n/a | •• |
| 16959 |
|
Nau G.J. |
Osteopontin |
n/a | •• |
| 16958 |
|
Nau G.J. |
Osteopontin Receptor |
n/a | •• |
| 16957 |
|
Schultz K. |
Ken Schultz's Field Guide to Freshwater Fish |
2003 | •• |
| 16956 |
|
Pan Z.Z. |
Opioid Research. Methods and Protocols |
2003 | •• |
| 16955 |
|
Bruce A.G., Rose T.M. |
Oncostatin M |
n/a | •• |
| 16954 |
|
Rose T.M., Bruce A.G. |
OSM Receptor |
n/a | •• |
| 16953 |
|
Hurst J.M. |
Profit Magic of Stock Transaction Timing |
1973 | •• |
| 16952 |
|
Thomsett M.C. |
Mastering Fundamental Analysis |
1998 | •• |
| 16951 |
|
Schein C.H. |
Nuclease Methods and Protocols |
2001 | •• |
| 16950 |
|
Webster R.A. |
Neurotransmitters, Drugs and Brain Function |
2001 | •• |
| 16949 |
|
Weinstock J.V. |
Neurokinin 1 |
n/a | •• |
| 16948 |
|
Potter N.T. |
Neurogenetics. Methods and Protocols |
2002 | •• |
| 16947 |
|
Mattson M.P. |
Neurobiology of Aggression: Understanding and Preventing Violence |
2003 | •• |
| 16946 |
|
Murphy J.J. |
Technical Analysis of the Financial Markets: A Comprehensive Guide to Trading Methods and Applications |
1999 • | •• |
| 16945 |
|
O'Donahue J. |
Java Database Programming Bible |
2002 | •• |
| 16944 |
|
Winkelmann G. (ed.) |
Microbial Transport Systems |
2001 | •• |
| 16943 |
|
Youn B.-S., Kwon B.S. |
Mu C10 |
n/a | •• |
| 16942 |
|
Nass S.J., Stillman B.W. |
Large-Scale Biomedical Science: Exploring Strategies for Future Research |
2003 | •• |
| 16941 |
|
Valeur B. |
Molecular Fluorescence: Principles and Applications |
2001 | •• |
| 16939 |
|
Decker J., Reischl U. |
Molecular Diagnosis of Infectious Diseases |
2003 • | •• |
| 16938 |
|
Elles R., Mountford R. |
Molecular Diagnosis of Genetic Diseases |
2003 • | •• |
| 16936 |
|
Holzenburg A., Scrutton N.S. (eds.) |
Enzyme-Catalyzed Electron and Radical Transfer |
2003 | •• |
| 16935 |
|
Crocker J., Murray P.G. (eds.) |
Molecular Biology in Cellular Pathology |
2003 • | •• |
| 16934 |
|
Ruddle N., Ware C.F. |
Lymphotoxin β Receptor |
n/a | •• |
| 16933 |
|
Papaihanassiu A.E., Green S.J., Grella D.K. |
Methoxyestradiol |
n/a | •• |
| 16932 |
|
Youn B.-S., Kwon B.S. |
Leukotactin 1 |
n/a | •• |
| 16931 |
|
Rollins B.J. |
ÌÑÐ-1, ÌÑÐ-2, ÌÑÐ-3, ÌÑÐ-4, and MCP-5 |
n/a | •• |
| 16930 |
|
Maiden M.C.J., Pollard A.J. |
Meningococcal Disease. Methods and Protocols |
2001 | •• |
| 16929 |
|
Farber J.M. |
MIG |
n/a | •• |
| 16927 |
|
Catron D.J., Zlotnik A. |
Lymphotactin |
n/a | •• |
| 16926 |
|
Chiang N., Gronert K., Qiu F.H. |
Lipoxin A4 Receptor |
n/a | •• |
| 16925 |
|
Clark I.M. |
Matrix Metalloproteinase Protocols |
2000 | •• |
| 16924 |
|
Sgaramella V., Eridani S. |
Mammalian Artificial Chromosomes. Methods and Protocols |
2003 | •• |
| 16923 |
|
Doolan D.L. |
Malaria Methods and Protocols |
2002 | •• |
| 16922 |
|
Chantry D., Gray P.W. |
Macrophage-derived Chemokine |
n/a | •• |
| 16921 |
|
Danilkovitch-Miagkova A,, Leonard E.J. |
Macrophage-Stimulating Protein (MSP) |
n/a | •• |
| 16920 |
|
Youn B.S., Kwon B.S. |
MIP-1γ/MRP-2 |
n/a | •• |
| 16919 |
|
Sherry B., Franchin G. |
MIP-1α, MIP-1β |
n/a | •• |
| 16918 |
|
Lam B.K., Austen F.K. |
Leukotriene B4 |
n/a | •• |
| 16917 |
|
Metz C.N., Bucala R. |
MIF |
n/a | •• |
| 16916 |
|
Wang D., Richmond A. |
MGSA/GRO |
n/a | •• |
| 16915 |
|
Levy B.D., Clish C.B., Croncrt K. |
Lipoxin |
n/a | •• |
| 16914 |
|
Seger R. |
MAP Kinase Signaling Protocols |
2004 | •• |
| 16913 |
|
Goetzl E.J., An S., Lee H. |
Lysophospholipid Growth Factor Receptors |
n/a | •• |
| 16912 |
|
Goetzl E.J., Lee H., Tigyi G.J. |
Lysophospholipid Growth Factors |
n/a | •• |
| 16911 |
|
Ruddle N., Ware C.F. |
Lymphotoxin α and β |
n/a | •• |
| 16910 |
|
Gylmore B. |
Dynamic Time and Price Analysis of Market Trends |
1997 | •• |
| 16909 |
|
Brakmann S. (ed.), Johnson K. (ed.) |
Directed Molecular Evolution of Proteins |
2002 | •• |
|
|
Î ïðîåêòå